The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer
Authors:
- Ofer N. GofritOGOfer N. Gofrit
- Kevin C. ZornKZKevin C. Zorn
- Josephine SilvestreJSJosephine Silvestre
- Arieh L. ShalhavASArieh L. Shalhav
- Gregory P. ZagajaGZGregory P. Zagaja
- Lambda P. MsezaneLMLambda P. Msezane
- Gary D. SteinbergGSGary D. Steinberg
- 1 May 2008
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 26 (3) , 246-249
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Multi‐target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancerInternational Journal of Cancer, 2006
- Watchful Waiting Policy in Recurrent Ta G1 Bladder TumorsEuropean Urology, 2006
- Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerBJU International, 2003
- Expectant Management of Small, Recurrent, Noninvasive Papillary Bladder TumorsJournal of Urology, 2003
- Multitarget Fluorescence In Situ Hybridization Assay Detects Transitional Cell Carcinoma in the Majority of Patients with Bladder Cancer and Atypical or Negative Urine CytologyJournal of Urology, 2003
- Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder CancerJournal of Urology, 2002
- Multiprobe FISH for Enhanced Detection of Bladder Cancer in Voided Urine Specimens and Bladder WashingsAmerican Journal of Clinical Pathology, 2001
- A COMPARISON OF CYTOLOGY AND FLUORESCENCE IN SITU HYBRIDIZATION FOR THE DETECTION OF UROTHELIAL CARCINOMAJournal of Urology, 2000